Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Treatment Interruption of Natalizumab

NCT01071083

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Cullman, Alabama, United States
  • Research Site San Francisco, California, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Pompano Beach, Florida, United States
View all 33 locations
View Trial Details
Completed

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

NCT00168766

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • CUB Hôpital Erasme Brussels, Belgium
  • Coordinating Research Site Copenhagen, Denmark
  • Rigshospitalet Skleroseklinikken, Denmark
  • Tampereen yliopistollinen sairaala - Neurologian klinikka Tampere, Finland
View Trial Details
Completed

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

NCT01075880

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Neurologicka klinika FNBB Brno, Czechia
  • Neurologicka klinika, Fakultní nemocnice U Sv. Anny Brno, Czechia
  • Neurologicke oddeleni KN. České Budějovice, Czechia
  • Neurologicka klinika Fakultní nemocnice Hradec Králové, Czechia
View all 13 locations
View Trial Details

Related conditions